TwinStrand Biosciences gathers $16 mln Series A

TwinStrand Biosciences, a genetic sequencing technology company, has raised $16 million in Series A funding.

TwinStrand Biosciences, a genetic sequencing technology company, has raised $16 million in Series A funding. Madrona Venture Group led the round with participation from Alexandria Venture Investments, Ridgeback Capital and Sahsen Ventures.

Source: Press Release